Long-term safety and efficacy of pregabalin as treatment of painful diabetic neuropathy: findings from 7 open-label extension studies

被引：0
|
作者：
Murphy, K. [1 ]
Emir, B. [1 ]
机构：
[1] Pfizer Inc, New York, NY USA
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1246
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of pregabalin as treatment of painful diabetic neuropathy (DPN): Findings from open-label extension studies
    Freeman, Roy
    D'Urso-Decruz, Edith
    Murphy, T. Kevin
    Emir, Birol
    [J]. DIABETES, 2008, 57 : A151 - A151
  • [2] Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial
    Shaibani, Aziz
    Biton, Victor
    Rauck, Richard
    Koch, Brigitte
    Simpson, Jeffrey
    [J]. EUROPEAN JOURNAL OF PAIN, 2009, 13 (05) : 458 - 463
  • [3] Efficacy safety and toleration of pregabalin as a treatment for painful diabetic neuropathy
    Koumoutsea, D.
    Chouliaras, E.
    Kalakonas, S.
    Tsiligiris, V
    Aslanoglou, D.
    Thalassinou, P.
    Thalassinos, N.
    Karydis, I
    Megas, I
    Hatziioannidis, A.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 : 83 - 83
  • [4] Long-Term Treatment of Diabetic Neuropathy with Lacosamide: Results from Two Long-Term Open-Label Trials
    Graf, Ronald
    Frye, Wendy
    Simpson, Jeffrey
    Jay, Gary
    Simpson, Karen
    Tzschaschel, Barbara
    Bongardt, Sabine
    Koch, Brigitte
    [J]. NEUROLOGY, 2009, 72 (11) : A212 - A212
  • [5] An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (06) : 1108 - 1115
  • [6] The efficacy and safety characteristics of long-term pregabalin treatment of neuropathic pain (NeP) associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN) in treatment-refractory patients: Findings from an open-label trial
    D'Urso-De Cruz, E
    Dworkin, R
    Stacey, B
    Siffert, J
    Fukui, A
    Emir, B
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S497 - S498
  • [7] Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study
    Donofrio, PD
    Raskin, P
    Rosenthal, NR
    Hewitt, DJ
    Jordan, DM
    Xiang, J
    Vinik, AI
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (09) : 1420 - 1431
  • [8] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [9] Long-Term Efficacy and Safety with Lanreotide Autogel/ Depot (LAN) from CLARINET and Open-Label Extension (OLE) Studies
    Phan, A. T.
    Pavel, M.
    Caplin, M.
    Wolin, E. M.
    Mirakhur, B.
    Massien, C.
    Liyanage, N.
    Lowenthal, Pittman S.
    Ruszniewski, P.
    [J]. NEUROENDOCRINOLOGY, 2017, 105 : 207 - 207
  • [10] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
12345